We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Humana Inc (HUM) is a leading healthcare plans business with stocks listed in the US. It opened the day at US$457.65 after a previous close of US$454.5. During the day the price has varied from a low of USD455.36 to a high of USD458.36. The latest price was USD455.65 (25 minute delay). Humana is listed on the NYSE. All prices are listed in US Dollars.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| Open | US$457.65 |
|---|---|
| High | US$458.36 |
| Low | US$455.36 |
| Close | US$455.65 |
| Previous close | US$454.5 |
| Change | US$1.15 |
| Change % | 0.253% |
| Volume | 416,897 |
| 52-week range | US$368.3751 - US$473.8507 |
|---|---|
| 50-day moving average | US$412.2866 |
| 200-day moving average | US$429.9683 |
| Target price | US$486.46 |
| PE ratio | 24.4288 |
| Dividend yield | US$2.65 (0.58%) |
| Earnings per share (TTM) | US$18.906 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.
Historical closes compared with the last close of $455.65
| 1 week (2021-10-14) | 4.75% |
|---|---|
| 1 month (2021-09-24) | 14.22% |
| 3 months (2021-07-23) | -3.30% |
| 6 months (2021-04-23) | 1.56% |
| 1 year (2020-10-23) | 2.55% |
|---|---|
| 2 years (2019-10-24) | 58.98% |
| 3 years (2018-10-24) | 43.40% |
| 5 years (2016-10-24) | 158.50% |
Valuing Humana stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Humana's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Humana's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Humana shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Humana's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3537. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Humana's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Humana's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$4.2 billion (£3.1 billion).
The EBITDA is a measure of a Humana's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | US$80.5 billion |
|---|---|
| Operating margin TTM | 4.89% |
| Gross profit TTM | US$15.5 billion |
| Return on assets TTM | 6.43% |
| Return on equity TTM | 16.97% |
| Profit margin | 3.09% |
| Book value | 115.506 |
| Market capitalisation | US$59.4 billion |
TTM: trailing 12 months
There are currently 1.8 million Humana shares held short by investors – that's known as Humana's "short interest". This figure is 7.6% down from 1.9 million last month.
There are a few different ways that this level of interest in shorting Humana shares can be evaluated.
Humana's "short interest ratio" (SIR) is the quantity of Humana shares currently shorted divided by the average quantity of Humana shares traded daily (recently around 739972.08333333). Humana's SIR currently stands at 2.4. In other words for every 100,000 Humana shares traded daily on the market, roughly 2400 shares are currently held short.
However Humana's short interest can also be evaluated against the total number of Humana shares, or, against the total number of tradable Humana shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Humana's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Humana shares in existence, roughly 10 shares are currently held short) or 0.0138% of the tradable shares (for every 100,000 tradable Humana shares, roughly 14 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Humana.
Find out more about how you can short Humana stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Humana.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 25.71
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Humana's overall score of 25.71 (as at 12/31/2018) is pretty good – landing it in it in the 33rd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Humana is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 2.6/100
Humana's environmental score of 2.6 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Humana is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 18.54/100
Humana's social score of 18.54 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Humana is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 5.07/100
Humana's governance score puts it squarely in the 3rd percentile of companies rated in the same sector. That could suggest that Humana is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Humana scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Humana has, for the most part, managed to keep its nose clean.
Humana Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 25.71 |
|---|---|
| Total ESG percentile | 32.96 |
| Environmental score | 2.6 |
| Environmental score percentile | 3 |
| Social score | 18.54 |
| Social score percentile | 3 |
| Governance score | 5.07 |
| Governance score percentile | 3 |
| Level of controversy | 2 |
Dividend payout ratio: 17.76% of net profits
Recently Humana has paid out, on average, around 17.76% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.61% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Humana shareholders could enjoy a 0.61% return on their shares, in the form of dividend payments. In Humana's case, that would currently equate to about $2.65 per share.
While Humana's payout ratio might seem low, this can signify that Humana is investing more in its future growth.
Humana's most recent dividend payout was on 28 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 28 September 2021 (the "ex-dividend date").
Humana's shares were split on a 3:2 basis on 31 July 1991. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Humana shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Humana shares which in turn could have impacted Humana's share price.
Over the last 12 months, Humana's shares have ranged in value from as little as US$368.3751 up to US$473.8507. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Humana's is 0.8878. This would suggest that Humana's shares are less volatile than average (for this exchange).
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Shares in the wealth management giant have been largely stable in the last 6 months.
Everything we know about the Judo Capital Holdings IPO, plus information on how to buy in.
Everything we know about the Alloggio Group IPO, plus information on how to buy in.
Everything we know about the Larvotto Resources IPO, plus information on how to buy in.
Everything we know about the Vulcan Steel IPO, plus information on how to buy in.
Everything we know about the Artrya IPO, plus information on how to buy in.
Everything we know about the 8 Au IPO, plus information on how to buy in.
Everything we know about the Radiopharm Theranostics IPO, plus information on how to buy in.
The online retailer’s shares have lost more than half their value in the last 12 months.
